Craniometrix
Using AI to help dementia patients age at home
New York, United States · Founded 2022 · $6.0M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Website
- craniometrix.com
- Total Funding
- $6.0M
- Last Round
- $6.0M SeedAug 2022
- Rounds
- 1
About
Craniometrix has raised over $21 million to help make dementia suck less. Dementia is tough – but it can be easier. Turns out, if you give families the right non-clinical coaching and support, you can avoid 30% of hospitalizations for these patients. And Medicare has recently started paying for that coaching. We launched our care navigation service for dementia patients in July of 2025, hit $4M of ARR, and just raised a $15M Series A. We leverage AI to provide best-in-class care, alleviating the burden on providers. Come help us build!
Summary
Craniometrix is a Healthcare company based in New York, United States, founded in 2022. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Aug 2022. Investors include Quiet Capital, Defy.vc and Olive Tree Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2022
Investors
Similar Companies
Neuralink is building a brain-computer interface for medical needs and greater human potential.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

